10341-87-4Relevant articles and documents
Gronowitz et al.
, p. 463 (1967)
Cap-dependent endonuclease inhibitors
-
Paragraph 0330; 0343-0345; 0347, (2021/11/10)
The present invention provides a compound of formula (I) for inhibiting influenza virus replication. A pharmaceutically acceptable salt, metabolite, or prodrug thereof. The compounds can be used for preparing medicaments for treating influenza. The invention further discloses a method and for preparing the same, and a composition comprising the compound and a pharmaceutically acceptable carrier.
INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF
-
Paragraph 0233; 0243; 0291; 0293, (2020/08/09)
Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza.